First Wave BioPharma, Inc. ("First Wave BioPharma" or the "Company") (NASDAQ:FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI)
RiskOn International, Inc. (NASDAQ:ROI) ("RiskOn" or the "Company"), a technology holding company, expects to announce, on January 3, 2024, via a press release and various media outlets, its new generative artificial
Coherus BioSciences, Inc. (NASDAQ: CHRS) shares are trading higher Wednesday after the company announced the FDA approval of its pegfilgrastim delivery device, Udenyca Onbody.
Aviation services provider AAR Corp (NYSE: AIR) has signed a multi-year contract extension and expansion for flight-hour component support services with
Tesla Inc (NASDAQ: TSLA) is gearing up to unveil a new version of its popular Model Y vehicle as it battles for EV market share amid increasing competition in the space,